CCOC(OC(C)=O)[C@@H]1C=C[C@H](C)N(c2ccc([N+](=O)[O-])cc2)O1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?